Swedbank AB Purchases 207,660 Shares of Intuitive Surgical, Inc. $ISRG

Key Points

• Swedbank AB has significantly increased its stake in Intuitive Surgical, raising its holdings by 112.4% to a total of 392,349 shares, valued at approximately $194.3 million.
• Multiple hedge funds have also boosted their positions in Intuitive Surgical, with notable increases including Chilton Capital Management, which raised its position by 614.3%.
• Analyst ratings for Intuitive Surgical vary, with a mix of 13 buy ratings, 6 hold ratings, and 1 sell rating, leading to an average target price of approximately $595.95.

Swedbank AB increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 112.4% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 392,349 shares of the medical equipment provider's stock after buying an additional 207,660 shares during the quarter. Swedbank AB owned 0.11% of Intuitive Surgical worth $194,319,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of the company. Chilton Capital Management LLC boosted its position in Intuitive Surgical by 614.3% during the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock valued at $25,000 after purchasing an additional 43 shares during the last quarter. Global Financial Private Client LLC boosted its position in Intuitive Surgical by 253.3% during the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock valued at $26,000 after purchasing an additional 38 shares during the last quarter. Elite Financial Inc. acquired a new position in Intuitive Surgical during the first quarter valued at approximately $26,000. LFA Lugano Financial Advisors SA acquired a new position in Intuitive Surgical during the first quarter valued at approximately $30,000. Finally, TD Capital Management LLC boosted its position in Intuitive Surgical by 300.0% during the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider's stock valued at $30,000 after purchasing an additional 45 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

ISRG has been the subject of several recent research reports. Zacks Research cut Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, August 20th. Truist Financial increased their price target on Intuitive Surgical from $590.00 to $600.00 and gave the company a "buy" rating in a research report on Wednesday, July 23rd. Erste Group Bank reissued a "hold" rating on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Citigroup reissued a "buy" rating and set a $650.00 price target (up from $590.00) on shares of Intuitive Surgical in a research report on Thursday, May 22nd. Finally, Wall Street Zen raised Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Saturday, July 26th. Thirteen equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $595.95.

Intuitive Surgical Stock Up 1.3%

ISRG opened at $455.85 on Friday. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00. The stock has a market cap of $163.41 billion, a price-to-earnings ratio of 63.58, a PEG ratio of 4.72 and a beta of 1.61. The business has a 50 day moving average of $487.55 and a 200-day moving average of $509.57.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The company had revenue of $2.44 billion during the quarter, compared to analysts' expectations of $2.35 billion. During the same period last year, the firm posted $1.78 earnings per share. The business's revenue was up 21.4% on a year-over-year basis. As a group, analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Transactions at Intuitive Surgical

In other news, EVP Myriam Curet sold 4,500 shares of the stock in a transaction that occurred on Friday, July 25th. The stock was sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the transaction, the executive vice president owned 353 shares in the company, valued at approximately $173,845.44. This trade represents a 92.73% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Gary S. Guthart sold 29,360 shares of the stock in a transaction that occurred on Friday, August 29th. The stock was sold at an average price of $472.49, for a total value of $13,872,306.40. Following the transaction, the insider owned 19,827 shares in the company, valued at approximately $9,368,059.23. This trade represents a 59.69% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 45,224 shares of company stock worth $21,716,492. Company insiders own 0.70% of the company's stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.